CV Sciences Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,243.70
2,302.40
518.50
1,057.50
2,791.50
12,935
Total Accounts Receivable
1,430.20
1,790.90
1,488.20
360.50
1,507.80
3,340
Inventories
2,473.30
11,666.30
14,133.90
2,851.80
2,822.60
7,132
Other Current Assets
1,909.10
1,046.70
451.10
551.40
813.20
2,059
Total Current Assets
8,056.30
16,806.30
16,591.70
4,821.10
7,935.20
25,466
Net Property, Plant & Equipment
214.10
516.40
439.60
242.70
2,083.40
2,844
Total Investments and Advances
439.20
-
-
-
-
-
Long-Term Note Receivable
310.30
26.70
-
389.70
-
-
Intangible Assets
5,212.00
4,390.50
10,263.80
6,659.90
6,624.50
6,589
Other Assets
-
-
-
6,478.70
6,067.10
2,003
Total Assets
14,232.00
21,739.90
27,295.20
18,592.20
22,710.20
36,902
ST Debt & Current Portion LT Debt
-
-
1,020.80
2,023.90
726.30
Accounts Payable
24.60
546.40
659.40
523.60
678.30
Other Current Liabilities
398.00
118.20
772.70
601.00
1,931.90
Total Current Liabilities
422.60
664.60
2,452.90
3,148.50
3,336.50
Long-Term Debt
5,502.60
-
-
679.20
850.00
Deferred Taxes
-
-
1,556.30
1,556.30
1,074.80
Other Liabilities
-
-
-
-
1,067.50
Total Liabilities
5,925.20
664.60
4,009.20
5,384.00
6,328.70
Common Equity (Total)
8,306.80
21,075.30
23,286.00
13,208.10
16,381.50
Total Shareholders' Equity
8,306.80
21,075.30
23,286.00
13,208.10
16,381.50
Total Equity
8,306.80
21,075.30
23,286.00
13,208.10
16,381.50
Liabilities & Shareholders' Equity
14,232.00
21,739.90
27,295.20
18,592.20
22,710.20

About CV Sciences

View Profile
Address
2688 South Rainbow Boulevard
Las Vegas Nevada 89146
United States
Employees -
Website http://www.cvsciences.com
Updated 07/08/2019
CV Sciences, Inc. engages in the provision of consumer and pharmaceutical products. It offers nutraceutical, beauty care, specialty foods, vape, and other. It operates through the Consumer Products, and Specialty Pharmaceutical segments.